Volume 10, Issue 4 , Pages 261-269, December 2007
Drug-Eluting Particles for Interventional Pharmacology
Chemoembolization with drug-eluting particles has been recently introduced in the field of interventional oncology. In this review, we will describe the pharmacokinetic properties and efficacy of all commercially available or under investigation drug-eluting particles and discuss the potentials and future of this new form of transcatheter arterial therapy for liver cancer.
Keywords: chemoembolization, hepatocellular carcinoma, hepatic metastasis, drug-eluting particles, doxorubicin, irinotecan
To access this article, please choose from the options below
PII: S1089-2516(08)00004-8
doi:10.1053/j.tvir.2008.03.003
© 2007 Elsevier Inc. All rights reserved.
Volume 10, Issue 4 , Pages 261-269, December 2007
